A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients
Clinical trial NCT03849768 · UNKNOWN
Trial details
- NCT number
- NCT03849768
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2021-01-15
- Enrollment
- 429
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.